Long-Term Dementia Risk in Parkinson Disease

被引:5
|
作者
Gallagher, Julia [1 ]
Gochanour, Caroline [4 ]
Caspell-Garcia, Chelsea [4 ]
Dobkin, Roseanne D. [5 ]
Aarsland, Dag [6 ]
Alcalay, Roy N. [7 ,8 ]
Barrett, Matthew J. [9 ]
Chahine, Lana [10 ]
Chen-Plotkin, Alice S. [1 ]
Coffey, Christopher S. [4 ]
Dahodwala, Nabila [1 ]
Eberling, Jamie L. [11 ]
Espay, Alberto J. [12 ]
Leverenz, James B. [13 ]
Litvan, Irene [14 ]
Mamikonyan, Eugenia [2 ]
Morley, James [1 ,15 ]
Richard, Irene H. [16 ]
Rosenthal, Liana [17 ]
Siderowf, Andrew D. [1 ]
Simuni, Tatyana [18 ]
York, Michele K. [19 ,20 ]
Willis, Allison W. [1 ]
Xie, Sharon X. [3 ]
Weintraub, Daniel [1 ,2 ,15 ]
机构
[1] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA
[3] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA USA
[4] Univ Iowa, Dept Biostat, Iowa City, IA USA
[5] Rutgers State Univ, Dept Psychiat, Newark, NJ USA
[6] Kings Coll London, Dept Old Age Psychiat, London, England
[7] Tel Aviv Sourasky Med Ctr, Neurol Inst, Tel Aviv, Israel
[8] Columbia Univ, Irving Med Ctr, Dept Neurol, New York, NY USA
[9] Virginia Commonwealth Univ, Dept Neurol, Richmond, VA USA
[10] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA USA
[11] Michael J Fox Fdn Parkinsons Res, New York, NY USA
[12] Univ Cincinnati, James J & Joan A Gardner Family Ctr Parkinsons Dis, Dept Neurol, Cincinnati, OH USA
[13] Cleveland Clin, Neurol Inst, Lou Ruvo Ctr Brain Hlth, Cleveland, OH USA
[14] Univ Calif San Diego, Dept Neurosci, La Jolla, CA USA
[15] Crescenz Vet Affairs Med Ctr, Parkinsons Dis Res Educ & Clin Ctr PADRECC, Philadelphia, PA 19104 USA
[16] Univ Rochester, Dept Neurol, Rochester, NY USA
[17] Johns Hopkins Univ, Dept Neurol, Baltimore, MD USA
[18] Northwestern Univ, Dept Neurol, Chicago, IL USA
[19] Baylor Coll Med, Dept Neurol, Houston, TX USA
[20] Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX USA
关键词
MILD COGNITIVE IMPAIRMENT; DIAGNOSTIC-CRITERIA; INCIDENT; MULTICENTER; PROGRESSION; MOCA;
D O I
10.1212/WNL.0000000000209699
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Objectives It is widely cited that dementia occurs in up to 80% of patients with Parkinson disease (PD), but studies reporting such high rates were published over two decades ago, had relatively small samples, and had other limitations. We aimed to determine long-term dementia risk in PD using data from two large, ongoing, prospective, observational studies. Methods Participants from the Parkinson's Progression Markers Initiative (PPMI), a multisite international study, and a long-standing PD research cohort at the University of Pennsylvania (Penn), a single site study at a tertiary movement disorders center, were recruited. PPMI enrolled de novo, untreated PD participants and Penn a convenience cohort from a large clinical center. For PPMI, a cognitive battery is administered annually, and a site investigator makes a cognitive diagnosis. At Penn, a comprehensive cognitive battery is administered either annually or biennially, and a cognitive diagnosis is made by expert consensus. Interval-censored survival curves were fit for time from PD diagnosis to stable dementia diagnosis for each cohort, using cognitive diagnosis of dementia as the primary end point and Montreal Cognitive Assessment (MoCA) score <21 and Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part I cognition score >= 3 as secondary end points for PPMI. In addition, estimated dementia probability by PD disease duration was tabulated for each study and end point. Results For the PPMI cohort, 417 participants with PD (mean age 61.6 years, 65% male) were followed, with an estimated probability of dementia at year 10 disease duration of 9% (site investigator diagnosis), 15% (MoCA), or 12% (MDS-UPDRS Part I cognition). For the Penn cohort, 389 participants with PD (mean age 69.3 years, 67% male) were followed, with 184 participants (47% of cohort) eventually diagnosed with dementia. The interval-censored curve for the Penn cohort had a median time to dementia of 15 years (95% CI 13-15); the estimated probability of dementia was 27% at 10 years of disease duration, 50% at 15 years, and 74% at 20 years. Discussion Results from two large, prospective studies suggest that dementia in PD occurs less frequently, or later in the disease course, than previous research studies have reported.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Prevalence of Antipsychotic Use in Long-Term Care Residents with Parkinson Dementia
    Zarowitz, Barbara J.
    GERIATRIC NURSING, 2012, 33 (03) : 217 - 219
  • [22] Physical activity may not be associated with long-term risk of dementia and Alzheimer's disease
    Kunutsor, Setor K.
    Laukkanen, Jari A.
    Kauhanen, Jussi
    Willeit, Peter
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2021, 51 (03)
  • [23] Association Between Cardiovascular Disease and Long-term Exposure to Air Pollution With the Risk of Dementia
    Grande, Giulia
    Ljungman, Petter L. S.
    Eneroth, Kristina
    Bellander, Tom
    Rizzuto, Debora
    JAMA NEUROLOGY, 2020, 77 (07) : 801 - 809
  • [24] Long-term cognitive profile and incidence of dementia after STN-DBS in Parkinson's disease
    Aybek, Selma
    Gronchi-Perrin, Aline
    Berney, Alexandre
    Chiuve, Sabina Catalano
    Villemure, Jean-Guy
    Burkhard, Pierre R.
    Vingerhoets, Francois J. G.
    MOVEMENT DISORDERS, 2007, 22 (07) : 974 - 981
  • [25] Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: An active treatment extension study
    Poewe, W
    Wolters, E
    Emre, M
    Onofrj, M
    Hsu, CC
    Tekin, S
    Lane, R
    MOVEMENT DISORDERS, 2006, 21 (04) : 456 - 461
  • [26] Long-Term Use of Antibiotics and Risk of Parkinson's Disease in the Nurses' Health Study
    Palacios, Natalia
    O'Reilly, Eilis J.
    Schwarzschild, Michael A.
    Ascherio, Alberto
    PARKINSONS DISEASE, 2020, 2020
  • [27] Beta2-adrenoreceptor agonists and long-term risk of Parkinson?s disease
    Tuominen, Julia A.
    Bjornevik, Kjetil
    Romanowska, Julia
    Solheim, Magne H.
    Grydeland, Thomas B.
    Cortese, Marianna
    Scherzer, Clemens R.
    Riise, Trond
    Igland, Jannicke
    PARKINSONISM & RELATED DISORDERS, 2023, 110
  • [28] Long-term efficacy of rasagiline in Parkinson's disease
    Lew, M
    Hauser, R
    Hurtig, H
    Ondo, W
    Wojcieszek, J
    NEUROLOGY, 2005, 64 (06) : A396 - A396
  • [29] Long-term results with cisapride in Parkinson's disease
    Jost, WH
    Schimrigk, K
    MOVEMENT DISORDERS, 1997, 12 (03) : 423 - 425
  • [30] Long-term monitoring of gait in Parkinson's disease
    Moore, Steven T.
    MacDougall, Hamish G.
    Gracies, Jean-Michel
    Cohen, Helen S.
    Ondo, William G.
    GAIT & POSTURE, 2007, 26 (02) : 200 - 207